Exacerbation of idiopathic pulmonary fibrosis

• Published in: Terapevtic̆eskii arhiv Vol. 92; no. 3; pp. 73 - 77
• Main Authors: Avdeev, S. N., Gaynitdinova, V. V., Merzhoeva, Z. M., Neklyudova, G. V., Tsareva, N. A., Nuralieva, G. S.
• Format: Journal Article
• Language: Russian
• Published: "Consilium Medicum" Publishing house 27-03-2020
• Subjects: exacerbation; idiopathic pulmonary fibrosis; pah-specific therapy; pulmonary hypertension
• ISSN: 0040-3660; 2309-5342
• DOI: 10.26442/00403660.2020.03.000402

Idiopathic pulmonary fibrosis (IPF) is usually characterized by a chronic and slowly progressive course. According to several studies, a small number of patients with IPF (about 515%) develops an acute deterioration of deasese exacerbation of IPF. Exacerbations of IPF can occur at any time of the disease and sometimes becomes the first manifestation of IPF. Pulmonary hypertension in IPF is a fairly frequent complication, which leads to severe violations of gas exchange and reduced tolerance to physical stress. Currently, proven effective treatments for exacerbations of IPF do not exist, the management of this condition is based on supportive therapy (oxygen, respiratory support) and interventions with inadequate evidences (corticosteroids, immunosuppressant). During exacerbation of IPF a careful search of all the possible triggers is justified. In the presented clinical case of exacerbation of IPF there was demonstrated the efficacy of complex therapy including antifibrotic therapy, PAH-specific medicines and enhanced oxygen therapy.